SCHEDULE: BlackRock Discloses 13.1% Stake in STAAR Surgical

BlackRock, Inc. has filed an amended Schedule 13G reporting beneficial ownership of 13.1% of STAAR Surgical Co. common stock.

Summary

• BlackRock, Inc. reports beneficial ownership of 6,507,911 shares of STAAR Surgical Co. common stock.
• This holding represents 13.1% of the total outstanding common stock of the issuer.
• The filing is an Amendment No. 19 to the original Schedule 13G.
• BlackRock maintains sole voting power over 6,453,653 shares and sole dispositive power over 6,507,911 shares.
• The iShares Core S&P Small-Cap ETF is specifically identified as holding more than 5% of the issuer's common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral regulatory disclosure confirming existing institutional interest rather than a change in corporate strategy or financial performance.

Positives

• Institutional confidence indicated by a significant 13.1% ownership stake from a major asset manager.
• The filing confirms that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Negatives

• NA

Risks

• Market volatility associated with large institutional holdings.
• Potential for future divestment by the reporting entity which could impact share price.

Future Outlook

The filing does not provide specific forward-looking guidance regarding the issuer's business operations, as it is a regulatory disclosure of ownership.

Management Comments

• The reporting person certifies that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.

Industry Context

StockSavvy.ai notes that large-scale institutional filings like this are standard for major asset managers like BlackRock, reflecting passive investment strategies across index funds such as the iShares Core S&P Small-Cap ETF.

Comparison to Industry Standards

• The filing follows standard SEC regulatory requirements for institutional investors holding over 5% of a public company's equity.
• The disclosure structure is consistent with typical Schedule 13G filings by major global asset management firms.

Legal Proceedings

• None mentioned.

Related Party Transactions

• None mentioned.

Stakeholder Impact

• Shareholders may view the continued 13.1% stake by a major institutional investor as a sign of long-term stability.

Next Steps

• Continued monitoring of future 13G/13D filings for changes in institutional ownership levels.

Key Dates

Keywords

STAAR Surgical, BlackRock, Schedule 13G, Institutional Ownership, Common Stock, iShares